Imprimis NJOF, LLC recalls Epinephrine Lidocaine HCL, 0.25mg/mL and 7.5 mg/mL, 20x1 mL Vials per carton, Rx Only, Imprimis NJOF, 1705 Route 46 Wes…

Recall date

July 9, 2025

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0535-2025

FDA classification

Class II

Brand / firm

Imprimis NJOF, LLC

Sold / distributed

Nationwide in the USA

Why it was recalled

Sub-Potent Drug: Subpotent assay results during stability testing.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Epinephrine Lidocaine HCL, 0.25mg/mL and 7.5 mg/mL, 20x1 mL Vials per carton, Rx Only, Imprimis NJOF, 1705 Route 46 West, Unit 6B Ledgewood, NJ, 07852 NDC: 71384-641-01